• Arcus Biosciences granted inducement equity awards to four new employees under its 2020 Inducement Plan.
• Options covered 21,200 shares at an exercise price of $26.39, set at the Sept. 23, 2026 closing price.
• Restricted stock units covered 10,650 shares of common stock.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcus Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260924045793) on September 24, 2026, and is solely responsible for the information contained therein.